JP2013505273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013505273A5 JP2013505273A5 JP2012530106A JP2012530106A JP2013505273A5 JP 2013505273 A5 JP2013505273 A5 JP 2013505273A5 JP 2012530106 A JP2012530106 A JP 2012530106A JP 2012530106 A JP2012530106 A JP 2012530106A JP 2013505273 A5 JP2013505273 A5 JP 2013505273A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- salt
- alkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical compound CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 235000011056 potassium acetate Nutrition 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- BWILYWWHXDGKQA-UHFFFAOYSA-M potassium propanoate Chemical compound [K+].CCC([O-])=O BWILYWWHXDGKQA-UHFFFAOYSA-M 0.000 claims description 2
- 239000004331 potassium propionate Substances 0.000 claims description 2
- 235000010332 potassium propionate Nutrition 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 claims description 2
- 239000004324 sodium propionate Substances 0.000 claims description 2
- 235000010334 sodium propionate Nutrition 0.000 claims description 2
- 229960003212 sodium propionate Drugs 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 0 *C(OC1=O)=NC1=CCc(cc1)ccc1-c1ccccc1 Chemical compound *C(OC1=O)=NC1=CCc(cc1)ccc1-c1ccccc1 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960004109 potassium acetate Drugs 0.000 description 1
- 229940093956 potassium carbonate Drugs 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2009/074125 WO2010034236A1 (en) | 2008-09-24 | 2009-09-23 | Process for the manufacture of n-acylbiphenyl alanine |
| CNPCT/CN2009/074125 | 2009-09-23 | ||
| PCT/CN2010/071243 WO2011035569A1 (en) | 2009-09-23 | 2010-03-23 | Process for manufacture of n-acylbphenyl alanine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013505273A JP2013505273A (ja) | 2013-02-14 |
| JP2013505273A5 true JP2013505273A5 (enExample) | 2013-05-09 |
| JP5894531B2 JP5894531B2 (ja) | 2016-03-30 |
Family
ID=43796233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530106A Active JP5894531B2 (ja) | 2009-09-23 | 2010-03-23 | Ｎ−アシルビフェニルアラニンを製造するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160115118A1 (enExample) |
| EP (1) | EP2480523B1 (enExample) |
| JP (1) | JP5894531B2 (enExample) |
| KR (2) | KR20120093227A (enExample) |
| CN (1) | CN102639486B (enExample) |
| AU (1) | AU2010297892B2 (enExample) |
| BR (1) | BR112012006406A2 (enExample) |
| CA (1) | CA2772681C (enExample) |
| IN (1) | IN2012DN01968A (enExample) |
| RU (1) | RU2534619C2 (enExample) |
| WO (1) | WO2011035569A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA33364B1 (fr) | 2009-05-28 | 2012-06-01 | Novartis Ag | Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine |
| MX2011012628A (es) | 2009-05-28 | 2011-12-14 | Novartis Ag | Derivados amino-propionicos sustituidos como inhibidores de neprilisina. |
| JO2967B1 (en) | 2009-11-20 | 2016-03-15 | نوفارتس ايه جي | Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors |
| AU2014216417B2 (en) | 2013-02-14 | 2016-05-12 | Novartis Ag | Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy |
| HRP20180958T1 (hr) | 2013-02-14 | 2018-07-27 | Novartis Ag | Supstituirani derivati bisfenolbutanfosfonske kiseline kao inhibitori za nep (neutralnu endopeptidazu) |
| TW201632493A (zh) | 2015-02-13 | 2016-09-16 | 諾華公司 | 新穎方法 |
| WO2017051326A1 (en) | 2015-09-23 | 2017-03-30 | Novartis Ag | New processes and intermediates useful in synthesis of nep inhibitors |
| CN108602785B (zh) | 2015-12-10 | 2023-08-11 | 诺华股份有限公司 | 新的工艺和中间体 |
| WO2018007919A1 (en) | 2016-07-05 | 2018-01-11 | Novartis Ag | New process for early sacubitril intermediates |
| US10851059B2 (en) | 2016-08-17 | 2020-12-01 | Novartis Ag | Processes and intermediates for NEP inhibitor synthesis |
| CN107778192A (zh) * | 2016-08-26 | 2018-03-09 | 浙江九洲药业股份有限公司 | 一种n‑烷氧或苄氧羰基手性氨酸的制备方法 |
| ES2883363T3 (es) | 2016-12-23 | 2021-12-07 | Novartis Ag | Proceso nuevo para intermedios iniciales de sacubitrilo |
| UY38072A (es) | 2018-02-07 | 2019-10-01 | Novartis Ag | Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60185752A (ja) * | 1984-03-05 | 1985-09-21 | Mitsui Toatsu Chem Inc | α−アセトアミド桂皮酸類の製造法 |
| JPS60215657A (ja) * | 1984-04-10 | 1985-10-29 | Mitsui Toatsu Chem Inc | Ｎ−アシルフエニルアラニン類の製造法 |
| JPS6245554A (ja) * | 1985-08-23 | 1987-02-27 | Nippon Redarii Kk | ４−ビフエニリル酢酸の簡易製造法 |
| CA1325222C (en) * | 1985-08-23 | 1993-12-14 | Lederle (Japan), Ltd. | Process for producing 4-biphenylylacetic acid |
| FR2662440B1 (fr) * | 1990-05-22 | 1992-07-31 | Rhone Poulenc Sante | Procede de preparation stereoselective de derives de la phenylisoserine. |
| IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| GB2354440A (en) * | 1999-07-20 | 2001-03-28 | Merck & Co Inc | Aryl amides as cell adhesion inhibitors |
| JP4270484B2 (ja) * | 2002-03-08 | 2009-06-03 | 第一ファインケミカル株式会社 | 光学活性フェニルアラニン誘導体の製造方法 |
| MXPA05000020A (es) * | 2002-07-01 | 2005-12-05 | Pharmacia & Upjohn Co Llc | Inhibidores de polimerasa ns5b de la infeccion del virus de la hepatitis c (hcv). |
| US20040180943A1 (en) * | 2002-07-23 | 2004-09-16 | Augelli-Szafran Corinne Elizabeth | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis |
| AR070176A1 (es) | 2008-01-17 | 2010-03-17 | Novartis Ag | Procesos de sintesis de inhibidores de nep, compuestos intermediarios y uso de los mismos en la sintesis |
| CN101684077B (zh) * | 2008-09-24 | 2013-01-02 | 浙江九洲药业股份有限公司 | N-酰基联苯丙氨酸的制备方法 |
| CN101774941A (zh) * | 2009-01-13 | 2010-07-14 | 浙江九洲药业股份有限公司 | 2-酰基氨基-3-联苯基丙酸的制备及拆分方法 |
| CN101555211B (zh) * | 2009-05-13 | 2012-01-25 | 浙江九洲药业股份有限公司 | 2-酰基氨基-3-联苯基丙酸的化学合成方法 |
-
2010
- 2010-03-23 BR BR112012006406A patent/BR112012006406A2/pt not_active Application Discontinuation
- 2010-03-23 EP EP10818263.5A patent/EP2480523B1/en active Active
- 2010-03-23 KR KR1020127010180A patent/KR20120093227A/ko not_active Ceased
- 2010-03-23 CN CN201080042243.1A patent/CN102639486B/zh active Active
- 2010-03-23 WO PCT/CN2010/071243 patent/WO2011035569A1/en not_active Ceased
- 2010-03-23 KR KR1020167036201A patent/KR101821090B1/ko not_active Expired - Fee Related
- 2010-03-23 JP JP2012530106A patent/JP5894531B2/ja active Active
- 2010-03-23 IN IN1968DEN2012 patent/IN2012DN01968A/en unknown
- 2010-03-23 AU AU2010297892A patent/AU2010297892B2/en not_active Ceased
- 2010-03-23 CA CA2772681A patent/CA2772681C/en not_active Expired - Fee Related
- 2010-03-23 RU RU2012116208/04A patent/RU2534619C2/ru not_active IP Right Cessation
-
2016
- 2016-01-08 US US14/990,832 patent/US20160115118A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013505273A5 (enExample) | ||
| JP2013508406A5 (enExample) | ||
| JP2012515142A5 (enExample) | ||
| RU2012116208A (ru) | Способ получения n-ацилбифенилаланина | |
| CN103582622B (zh) | 经由亚胺鎓盐制备双环化合物的方法 | |
| JP2018535262A (ja) | ４−（（６−（２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−２−オキソエチル）ピリジン−３−イル）オキシ）ベンゾニトリル及び製造方法 | |
| CN110606842B (zh) | 吡啶胺基嘧啶衍生物的制备方法及其中间体 | |
| AU2008339583A1 (en) | Processes to pregabalin | |
| KR20060135959A (ko) | 발사르탄 및 이의 전구체의 제조방법 | |
| CN108148044A (zh) | 酰胺类化合物及该化合物制备富马酸沃诺拉赞的方法 | |
| CN101528673B (zh) | 不对称铜络合物结晶的制造方法 | |
| CN104016877A (zh) | 一种苯基乙酰胺类化合物及在制备米拉贝隆中的应用 | |
| JP2009532428A5 (enExample) | ||
| CN104031031B (zh) | 一种制备达比加群酯的方法 | |
| JP5095945B2 (ja) | ４−トリフルオロメチルニコチン酸又はその塩の製造方法 | |
| EP2427434B1 (en) | Process for preparing bromo-substituted quinolines | |
| JP6359537B2 (ja) | 複素環エステル誘導体の調製プロセス | |
| JP4790901B2 (ja) | ４−アミノ−５−シアノイミダゾール誘導体及びその中間体の製造方法 | |
| EP3478684A1 (en) | New processes for the preparation of vemurafenib | |
| CN115023421B (zh) | 含氟嘧啶化合物及其制造方法 | |
| JP2009538850A5 (enExample) | ||
| JPWO2018168899A1 (ja) | ベンズイミダゾール誘導体の製造方法 | |
| CN102633717B (zh) | N-乙酰-喹啉-2(1h)酮类化合物及其制备方法和应用 | |
| JP2008105970A (ja) | ジヒドロキノリン誘導体の製造方法及びその中間体 | |
| JP2008133261A (ja) | 不斉銅錯体結晶の製造方法 |